Galapagos NV
GLPG
#4563
Rank
S$2.73 B
Marketcap
S$40.94
Share price
-0.57%
Change (1 day)
13.48%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : S$5.34 Billion

According to Galapagos NV's latest financial reports the company's total assets are S$5.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$5.84 B-8.05%
2023-12-31S$6.36 B-6.56%
2022-12-31S$6.80 B-14.37%
2021-12-31S$7.95 B-14.54%
2020-12-31S$9.30 B1.51%
2019-12-31S$9.16 B307.39%
2018-12-31S$2.24 B8.99%
2017-12-31S$2.06 B25.16%
2016-12-31S$1.64 B140.97%
2015-12-31S$0.68 B57.46%
2014-12-31S$0.43 B-13.56%
2013-12-31S$0.50 B32.09%
2012-12-31S$0.38 B40.54%
2011-12-31S$0.27 B-18.49%
2010-12-31S$0.33 B14.97%
2009-12-31S$0.28 B21.67%
2008-12-31S$0.23 B-23.98%
2007-12-31S$0.31 B-7.88%
2006-12-31S$0.33 B110.85%
2005-12-31S$0.16 B365.6%
2004-12-31S$34.55 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
S$148.32 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$249.87 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$197.39 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$173.51 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$0.20 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$109.09 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.64 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$106.86 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$167.87 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA